Bank of New York Mellon »

Inozyme Pharma shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 164k 7.66
2023-12-31 $673k 158k 4.26
2023-09-30 $593k 141k 4.20
2023-06-30 $789k 142k 5.57
2023-03-31 $270k 47k 5.73
2022-12-31 $21k 20k 1.05
2022-09-30 $54k 20k 2.67
2022-06-30 $105k 22k 4.79
2022-03-31 $165k 40k 4.12
2021-12-31 $280k 41k 6.80
2021-09-30 $469k 40k 11.60
2021-06-30 $624k 37k 17.06
2021-03-31 $459k 23k 19.67
2020-12-31 $439k 21k 20.56
2020-09-30 $509k 19k 26.24